Safety and Immunogenicity of Cell Culture-Derived A/H3N2 Variant Influenza Vaccines: A Phase I Randomized, Observer-Blind, Dose-Ranging Study
Supplementary Data
Supplementary Data
Files in this Data Supplement:
Supplementary Table 1
- docx file
Supplementary Table 2
- docx file